Events
Decision Making for Enhanced Health Security
SDP Free Webinar – February 2023
Speaker: Gilberto Montibeller
Moderator: Eyas Raddad
Emerging and re-emerging health threats have always been a central theme of our history; the recent COVID-19 pandemic being the latest of these unfortunate events and certainly not the last. The pandemic once again reminded us of the importance of reasoned decision making and responsible leadership for health security. (In fact, did you know the very first decision analysis was conducted on a health security decision problem in the 18th century?)
In this talk I argue that decision analysis has much to contribute to this important category of decision problems, which has specific challenges that must be addressed to support high-quality decisions. I propose a framework for supporting health security decision making that can address competing priorities and key uncertainties, mitigate critical risks in a cost-effective manner and maximize societal value.
Join us to learn about the fascinating true story of the first health security decision analysis and to jointly reflect on how we can improve the decision quality of private and public organizations which are confronted by health threats. Together we, the decision professionals, can help to enhance the health security of our societies.
Speaker: Gilberto Montibeller
Moderator: Eyas Raddad
Emerging and re-emerging health threats have always been a central theme of our history; the recent COVID-19 pandemic being the latest of these unfortunate events and certainly not the last. The pandemic once again reminded us of the importance of reasoned decision making and responsible leadership for health security. (In fact, did you know the very first decision analysis was conducted on a health security decision problem in the 18th century?)
In this talk I argue that decision analysis has much to contribute to this important category of decision problems, which has specific challenges that must be addressed to support high-quality decisions. I propose a framework for supporting health security decision making that can address competing priorities and key uncertainties, mitigate critical risks in a cost-effective manner and maximize societal value.
Join us to learn about the fascinating true story of the first health security decision analysis and to jointly reflect on how we can improve the decision quality of private and public organizations which are confronted by health threats. Together we, the decision professionals, can help to enhance the health security of our societies.
Add this event to your calendar
|
Location
Zoom Webinar
|
|
Dates
Feb 15, 2023
08:00 AM - 09:00 AM |
|
Contact
Hilda Cherekdjian
|
|
Respondent Email
|
Speaker
GILBERTO MONTIBELLER is Professor of Management Science and Director of Executive Education at Loughborough University (UK). He is also a Senior Research Fellow at the Center for Risk and Economic Analysis of Threats and Emergencies at the University of Southern California (USA), an Associate Editor of the INFORMS Decision Analysis Journal, and a member of the SDP Executive Board.
Dr. Montibeller is an expert in Behavioral Decision Analysis and Multi-Criteria Decision Analysis with an application focus on Health Decision Analysis and Health Operations. He provides decision consulting for private and public organizations, such as WHO, FAO, Roche, Novartis, DEFRA, the UK Department of Health, among others. In his spare time, he enjoys riding his motorbike along beautiful European roads.
Moderator
EYAS RADDAD is a seasoned drug discovery and development researcher, strategist, and innovator. Since he joined Eli Lilly and Company in 2001, he applied sophisticated data analytics and strategic frameworks to improve decision making in drug discovery and development process.
Over his career, he implemented Decision Analytic techniques in drug development applications. In 2017, Eyas established and led Research Decision Analytics function in Lilly Research Laboratories, with a mission that includes portfolio management, decision consulting and decision education. More recently, he has been serving a COO of multiple early development programs at Eli Lilly, as well as portfolio management role in Diabetes Research.
